Citations (72)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Piyong Sola, Praveen Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S.S Pindiprolu & Mamta Kumari. (2020) Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery 17:8, pages 1119-1132.
Read now
Read now
Bushra Nabi, Saleha Rehman, Mohammad Fazil, Saba Khan, Sanjula Baboota & Javed Ali. (2020) Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Development and Industrial Pharmacy 46:3, pages 471-483.
Read now
Read now
Yueyao Jiang, Chenqi Liu, Wanchen Zhai, Ning Zhuang, Tengfei Han & Zhiying Ding. (2019) The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route. International Journal of Nanomedicine 14, pages 9217-9234.
Read now
Read now
Saleha Rehman, Bushra Nabi, Ameeduzzafar Zafar, Sanjula Baboota & Javed Ali. (2019) Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?. Expert Opinion on Drug Delivery 16:12, pages 1355-1366.
Read now
Read now
Sanaa A. El-Gizawy, Gamal M. El-Maghraby & Asmaa A. Hedaya. (2019) Formulation of acyclovir-loaded solid lipid nanoparticles: 2. Brain targeting and pharmacokinetic study. Pharmaceutical Development and Technology 24:10, pages 1299-1307.
Read now
Read now
Rajalakshmi Rukmangathen, Indira Muzib Yallamalli & Prasanna Raju Yalavarthi. (2019) Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Drug Development and Industrial Pharmacy 45:8, pages 1342-1350.
Read now
Read now
Shengnan Tang, Aiping Wang, Xiuju Yan, Liuxiang Chu, Xiucheng Yang, Yina Song, Kaoxiang Sun, Xin Yu, Rongxia Liu, Zimei Wu & Peng Xue. (2019) Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease. Drug Delivery 26:1, pages 700-707.
Read now
Read now
Xiuju Yan, Lixiao Xu, Chenchen Bi, Dongyu Duan, Liuxiang Chu, Xin Yu, Zimei Wu, Aiping Wang & Kaoxiang Sun. (2018) Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects. International Journal of Nanomedicine 13, pages 273-281.
Read now
Read now
Niyaz Ahmad. (2017) Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's disease. Journal of Liquid Chromatography & Related Technologies 40:13, pages 677-690.
Read now
Read now
Abhijeet D. Kulkarni, Yogesh H. Vanjari, Karan H. Sancheti, Veena S. Belgamwar, Sanjay J. Surana & Chandrakantsing V. Pardeshi. (2015) Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review. Journal of Drug Targeting 23:9, pages 775-788.
Read now
Read now
Articles from other publishers (62)
Riya Joshi, Hemi Missong, Jayapriya Mishra, Satinder Kaur, Sumant Saini, Ramesh Kandimalla, P. Hemachandra Reddy, Arockia Babu, Gurjit Kaur Bhatti & Jasvinder Singh Bhatti. (2023) Nanotheranostics revolutionizing neurodegenerative diseases: From precision diagnosis to targeted therapies. Journal of Drug Delivery Science and Technology 89, pages 105067.
Crossref
Crossref
Prakash N. Kendre, Dhiraj R. Kayande, Shirish P. Jain, Tejaswini G. Malge, Namrata N. Zadpe & Bhupendra G. Prajapati. (2023) Polymeric Nanoparticles: Prospective on the Synthesis, Characterization
and Applications in Nose-to-Brain Drug Delivery. Current Nanoscience 19:5, pages 663-676.
Crossref
Crossref
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova & Jianqin Lu. (2023) Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology 15:5.
Crossref
Crossref
Youssef Ait Hamdan, Samia Elouali, Abdelali Ben Maloui, Bilal El-Mansoury, Hassane Oudadesse & Mohammed Rhazi. 2023. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease
253
274
.
Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang & Xin-Ying Ji. (2023) Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration. iScience 26:8, pages 107321.
Crossref
Crossref
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 358, pages 293-318.
Crossref
Crossref
Gurjeet Kaur, Jayant Goyal, Prabhat Kumar Behera, Sushma Devi, Sachin Kumar Singh, Varun Garg & Neeraj Mittal. (2023) Unraveling the role of chitosan for nasal drug delivery systems: A review. Carbohydrate Polymer Technologies and Applications 5, pages 100316.
Crossref
Crossref
Vanshita Singh, Akash Garg, Rajeev Sharma & Hitesh Kumar Dewangan. (2023) Recent Advances of Nanotechnology in Brain Targeting. Current Nanoscience 19:3, pages 350-361.
Crossref
Crossref
Prashant Pingale, Prakash Kendre, Krutika Pardeshi & Amarjitsing Rajput. (2023) An emerging era in manufacturing of drug delivery systems: Nanofabrication techniques. Heliyon 9:3, pages e14247.
Crossref
Crossref
Hala N. ElShagea, Rana R. Makar, Alaa H. Salama, Nermeen A. Elkasabgy & Emad B. Basalious. (2023) Investigating the Targeting Power to Brain Tissues of Intranasal Rasagiline Mesylate-Loaded Transferosomal In Situ Gel for Efficient Treatment of Parkinson’s Disease. Pharmaceutics 15:2, pages 533.
Crossref
Crossref
Deepshi Arora, Shailendra Bhatt, Manish Kumar, Rupesh K. Gautam, Yugam Taneja & Muskan Chauhan. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
447
477
.
Muhammad Sarfraz, Sara Mousa, Ranim Al Saoud & Raimar Löbenberg. 2023. Nasal Drug Delivery. Nasal Drug Delivery
339
360
.
Nicola Paccione, Mahdieh Rahmani, Emilia Barcia & Sofía Negro. (2022) Antiparkinsonian Agents in Investigational Polymeric Micro- and Nano-Systems. Pharmaceutics 15:1, pages 13.
Crossref
Crossref
Yong-Bo Zhang, Dong Xu, Lu Bai, Yan-Ming Zhou, Han Zhang & Yuan-Lu Cui. (2022) A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 14:9, pages 1974.
Crossref
Crossref
Marwa Eid Sayyed, Mohamed Abd El-Motaleb, Ismail Taha Ibrahim, Mohamed Ahmed El-Nabarawi & Mohamed Abdallah Ahmed. (2022) Intranasal administration of 99mTc-topiramate-loaded phospholipid magnesome potential route for enhanced brain delivery: Characterization, biodistribution, and pharmacokinetic behaviors. Journal of Drug Delivery Science and Technology 69, pages 103185.
Crossref
Crossref
Harsha Jain, Harshita Dalvi, Aditi Bhat, Aashruti Agrawal, Jitender Madan, Pankaj Kumar Singh, Neelesh Kumar Mehra, Shashi Bala Singh & Saurabh Srivastava. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
379
400
.
Pallavi Kiran, Sujit Kumar Debnath, Suditi Neekhra, Vaishali Pawar, Amreen Khan, Faith Dias, Shubham Pallod & Rohit Srivastava. (2021) Designing nanoformulation for the nose‐to‐brain delivery in Parkinson's disease: Advancements and barrier. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Crossref
David Lee & Tamara Minko. (2021) Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 13:12, pages 2049.
Crossref
Crossref
Ajit Singh, Sandeep Kumar Maharana, Rahul Shukla & Prashant Kesharwani. (2021) Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 110, pages 181-194.
Crossref
Crossref
Giada Botti, Alessandro Dalpiaz & Barbara Pavan. (2021) Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration. Pharmaceutics 13:8, pages 1144.
Crossref
Crossref
Tapasya R. Mulam, Sanjay J. Kshirsagar & Smita P. Kakad. (2021) FORMULATION AND OPTIMIZATION OF RITONAVIR NASAL NANOSUSPENSION FOR BRAIN TARGETING. INDIAN DRUGS 58:4, pages 28-41.
Crossref
Crossref
Hetal P. Patel, Priyanka S. Chaudhari, Priyanshi A. Gandhi, Bhargavi V. Desai, Ditixa T. Desai, Praful P. Dedhiya, Bhavin A. Vyas & Furqan A. Maulvi. (2021) Nose to brain delivery of tailored clozapine nanosuspension stabilized using (+)-alpha-tocopherol polyethylene glycol 1000 succinate: Optimization and in vivo pharmacokinetic studies. International Journal of Pharmaceutics 600, pages 120474.
Crossref
Crossref
Abhijeet Kulkarni, Mahesh Shinde, Gaurav Sonawane, Hitesh Raotole, Rohit Pande & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
329
349
.
Prashant Upadhaya, Sreeranjini Pulakkat & Vandana Patravale. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
287
303
.
Drashti Desai, Bala Prabhakar & Pravin Shende. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
57
71
.
Ikram Ahmad, Hina Tabassum, Farwa Batool Shamsi, Saad Maroof Saeed, Awais Ahmad & Shahid Hussain. 2021. Nanomedicine Manufacturing and Applications. Nanomedicine Manufacturing and Applications
173
191
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Manuela Curcio, Giuseppe Cirillo, Jourdin R. C. Rouaen, Federica Saletta, Fiore Pasquale Nicoletta, Orazio Vittorio & Francesca Iemma. (2020) Natural Polysaccharide Carriers in Brain Delivery: Challenge and Perspective. Pharmaceutics 12:12, pages 1183.
Crossref
Crossref
Anupam Sarma & Malay K. Das. (2020) Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS. Molecular Biomedicine 1:1.
Crossref
Crossref
Gi Doo Cha, Taegyu Kang, Seungmin Baik, Dokyoon Kim, Seung Hong Choi, Taeghwan Hyeon & Dae-Hyeong Kim. (2020) Advances in drug delivery technology for the treatment of glioblastoma multiforme. Journal of Controlled Release 328, pages 350-367.
Crossref
Crossref
Tanvi Kadam & Surendra Agrawal. (2020) A Short Review on the Important Aspects Involved in Preparation, Characterization and Application of Nanostructured Lipid Carriers for Drug Delivery. Current Nanomedicine 10:3, pages 188-207.
Crossref
Crossref
Amnon C. Sintov. (2020) AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin. International Journal of Pharmaceutics 588, pages 119725.
Crossref
Crossref
Geoffrey de Brouwer, Arina Fick, Ané Lombaard, Dan J. Stein, Brian H. Harvey & De Wet Wolmarans. (2020) Large nest building and high marble-burying: Two compulsive-like phenotypes expressed by deer mice (Peromyscus maniculatus bairdii) and their unique response to serotoninergic and dopamine modulating intervention. Behavioural Brain Research 393, pages 112794.
Crossref
Crossref
Monika Joshi, Ravi Shankar & Kamla Pathak. 2020. Progress in Adhesion and Adhesives. Progress in Adhesion and Adhesives
295
329
.
V.G. Sita, Dhananjay Jadhav & Pradeep Vavia. (2020) Niosomes for nose-to-brain delivery of bromocriptine: Formulation development, efficacy evaluation and toxicity profiling. Journal of Drug Delivery Science and Technology 58, pages 101791.
Crossref
Crossref
Saurabh Mittal, Muhammad U. Ashhar, Farheen F. Qizilbash, Zufika Qamar, Jasjeet K. Narang, Shobhit Kumar, Javed Ali & Sanjula Baboota. (2020) Ligand Conjugated Targeted Nanotherapeutics for Treatment of Neurological Disorders. Current Pharmaceutical Design 26:19, pages 2291-2305.
Crossref
Crossref
Doddy Denise Ojeda-Hernández, Alejandro A. Canales-Aguirre, Jorge Matias-Guiu, Ulises Gomez-Pinedo & Juan C. Mateos-Díaz. (2020) Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Somayeh Taymouri, Mohsen Minaiyan, Farnaz Ebrahimi & Naser Tavakoli. (2020) In‐vitro and in‐vivo evaluation of chitosan‐based thermosensitive gel containing lorazepam NLCs for the treatment of status epilepticus. IET Nanobiotechnology 14:2, pages 148-154.
Crossref
Crossref
Ramin Ansari, Seyed Mahdi Sadati, Negin Mozafari, Hajar Ashrafi & Amir Azadi. (2020) Carbohydrate polymer-based nanoparticle application in drug delivery for CNS-related disorders. European Polymer Journal 128, pages 109607.
Crossref
Crossref
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
89
101
.
Magisetty Obulesu. 2020. Parkinson's Disease Therapeutics. Parkinson's Disease Therapeutics
1
11
.
Areen Alshweiat, Rita Ambrus & IIdikó Csóka. (2019) Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery. Current Medicinal Chemistry 26:35, pages 6459-6492.
Crossref
Crossref
Rajalakshmi Rukmangathen, Indira Muzib Yallamalli & Prasanna Raju Yalavarthi. (2019) Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease. Current Drug Discovery Technologies 16:4, pages 417-425.
Crossref
Crossref
Elnaz Amanzadeh, Abolghasem EsmaeiliSoheila Rahgozar & Maryam Nourbakhshnia. (2019) Application of quercetin in neurological disorders: from nutrition to nanomedicine. Reviews in the Neurosciences 30:5, pages 555-572.
Crossref
Crossref
Vandana Soni, Vikas Pandey, Saket Asati, Priyanka Jain & Rakesh K. Tekade. 2019. Basic Fundamentals of Drug Delivery. Basic Fundamentals of Drug Delivery
539
593
.
Archana Khosa, Ranendra Narayan Saha & Gautam Singhvi. 2019. Nanomaterials for Drug Delivery and Therapy. Nanomaterials for Drug Delivery and Therapy
461
514
.
Meng Huang, Xiao Gu & Xiaoling Gao. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System
321
356
.
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Jacques Desbrieres, Catalina Peptu, Lacramiora Ochiuz, Corina Savin, Marcel Popa & Silvia Vasiliu. 2019. Sustainable Agriculture Reviews 36. Sustainable Agriculture Reviews 36
241
314
.
Hiba Natsheh & Elka Touitou. (2018) Phospholipid Magnesome—a nasal vesicular carrier for delivery of drugs to brain. Drug Delivery and Translational Research 8:3, pages 806-819.
Crossref
Crossref
Isra’ Zeiadeh, Anas Najjar & Rafik Karaman. (2018) Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review. Molecules 23:6, pages 1289.
Crossref
Crossref
Yunhai Feng, Haisheng He, Fengqian Li, Yi Lu, Jianping Qi & Wei Wu. (2018) An update on the role of nanovehicles in nose-to-brain drug delivery. Drug Discovery Today 23:5, pages 1079-1088.
Crossref
Crossref
Fabio Sonvico, Adryana Clementino, Francesca Buttini, Gaia Colombo, Silvia Pescina, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann & Sara Nicoli. (2018) Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting. Pharmaceutics 10:1, pages 34.
Crossref
Crossref
Shakeeb Ahmed, Azka Gull, Mahtab Alam, Mohd. Aqil & Yasmin Sultana. (2018) Ultrasonically tailored, chemically engineered and “QbD” enabled fabrication of agomelatine nanoemulsion; optimization, characterization, ex-vivo permeation and stability study. Ultrasonics Sonochemistry 41, pages 213-226.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
Patrícia C. Pires & Adriana O. Santos. (2018) Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. Journal of Controlled Release 270, pages 89-100.
Crossref
Crossref
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Crossref
S. Salatin, J. Barar, M. Barzegar-Jalali, Kh. Adibkia & M. Jelvehgari. (2017) Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies. Colloids and Surfaces B: Biointerfaces 159, pages 629-638.
Crossref
Crossref
Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy & Elaine Del-Bel. (2016) Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotoxicity Research 30:4, pages 715-729.
Crossref
Crossref
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) “Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ”. International Journal of Biological Macromolecules 89, pages 206-218.
Crossref
Crossref
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration. European Journal of Pharmaceutical Sciences 91, pages 196-207.
Crossref
Crossref
Naimat Kalim Bari, Mohammad Fazil, Md Quamrul Hassan, Md Rafi Haider, Bharti Gaba, Jasjeet K. Narang, Sanjula Baboota & Javed Ali. (2015) Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder. International Journal of Biological Macromolecules 81, pages 49-59.
Crossref
Crossref